RO112992B1 - Composition for radiobiological and chemical decontamination of uranium, radionuclides, of other noxious chemical products and method of treatment - Google Patents
Composition for radiobiological and chemical decontamination of uranium, radionuclides, of other noxious chemical products and method of treatmentInfo
- Publication number
- RO112992B1 RO112992B1 RO96-01722A RO9601722A RO112992B1 RO 112992 B1 RO112992 B1 RO 112992B1 RO 9601722 A RO9601722 A RO 9601722A RO 112992 B1 RO112992 B1 RO 112992B1
- Authority
- RO
- Romania
- Prior art keywords
- leaves
- days
- radiobiological
- composition
- flowers
- Prior art date
Links
Abstract
The invention relates to a composition for the radiobiological and chemical decontamination of uranium, radionuclides and other noxious chemical products, comprising 0.069 g of leaves and flowers of Urtica dioica L, 0.017 g of leaves of Equisetum arvense, 0.007 g of flowers of Matricaria chamomillae, 0.005 g of leaves of Vaccinum myrtilis, 0.002 g of leaves and flowers of Mentha pulegium. The invention relates to a method of treatment consisting in that, in the first step there is applied the milliizonizant- osmotic and anesthesic millimicropuncture for the purpose of initiating the phisiological- endocrinological acceptance on areas of 2...6 cm 2, in the subaural-jugular regions, bilateral in the direction of the hypophysis and in the regions adjacent to the suprarenals, and continues, in the second step, in the direction of the thyroid, thymus, epiphysis, pancreas, ovary and testicles, which amplifies the acceleration of the elimination on the natural way of the radioactive and toxic agent from the body, for 3...4 days, with the minor elements and chelating biochemical mediators in the composition of urticaria causing hairs from Urtica dioica L, in doses of 1...6 g/kg/day, for 3...35 minutes, and it is treated with capsules containing 0.10...0.15 g of pharmaceutical product, in doses of 1...3 capsules, administered orally, at 2...6 h, for 6...7 days, during this time interval there is analyzed daily the result of elimination of radiobiological substances based on which the treatment is stopped or continued, there resuming the steps at intervals of 6...7 days, with 3...4 days inbetween,
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RO96-01722A RO112992B1 (en) | 1996-08-28 | 1996-08-28 | Composition for radiobiological and chemical decontamination of uranium, radionuclides, of other noxious chemical products and method of treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RO96-01722A RO112992B1 (en) | 1996-08-28 | 1996-08-28 | Composition for radiobiological and chemical decontamination of uranium, radionuclides, of other noxious chemical products and method of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
RO112992B1 true RO112992B1 (en) | 2004-07-30 |
Family
ID=64361860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RO96-01722A RO112992B1 (en) | 1996-08-28 | 1996-08-28 | Composition for radiobiological and chemical decontamination of uranium, radionuclides, of other noxious chemical products and method of treatment |
Country Status (1)
Country | Link |
---|---|
RO (1) | RO112992B1 (en) |
-
1996
- 1996-08-28 RO RO96-01722A patent/RO112992B1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO942241D0 (en) | Method of Treating Osteoporosis in the Treatment of Bisphosphonates and Parathyroid Hormone | |
DE3889536T2 (en) | TREATING CANCER WITH SOMATOSTATIN AND WITH ANALOGS OF IT. | |
CA1262682C (en) | Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents | |
DE3880421D1 (en) | PHARMACEUTICAL PREPARATIONS FOR TREATING PSORIASIS, PSORIATIC ARTHRITIS, NEURODERMITIS AND ENTERITIS REGIONALIS CROHN. | |
Stern et al. | Antidepressant and memory effects of combined thyroid hormone treatment and electroconvulsive therapy: preliminary findings. | |
WO2001066275A3 (en) | Composite particles and methods of their use | |
DE69320646T2 (en) | METHOD FOR TREATING CANCER BY COMBINATION THERAPY WITH 2'-HALOMETHYLIDEN DERIVATIVES AND AN S- OR M-PHASE-SPECIFIC ANTINEOPLASTIC ACTIVE SUBSTANCE | |
WO1994008551A3 (en) | Pharmaceutical compositions and methods for treating cold symptoms | |
BG101603A (en) | Method for the decontamination of radioactive materials | |
UA32457C2 (en) | Drug (variants) and methods for exposure to drug | |
RO112992B1 (en) | Composition for radiobiological and chemical decontamination of uranium, radionuclides, of other noxious chemical products and method of treatment | |
NL183248C (en) | METHOD FOR REDUCING THE CURING DEFORMATION IN THE CARBONATION OF LARGE TOOTH WHEELS OF STEEL, AND A SUPPORT BODY FOR CARRYING OUT THIS PROCESS. | |
DE69841573D1 (en) | METHOD FOR INCREASING MAGNESIUM ABSORPTION AND PREVENTING ARTHEROSCLEROSIS | |
BR9406534A (en) | Method for the treatment of neoplastic disease using thiazofurin and ribavirin | |
NO982582L (en) | Procedure for the treatment of pain | |
ZA837972B (en) | Method of analgesic treatment and pharmaceutical compositions | |
IL90187A0 (en) | Method for treating an auto-immune disease using succinyl-acetone and pharmaceutical compositions containing the same | |
HU905683D0 (en) | The treatment of drug dependence by using sertraline | |
FR2690152B1 (en) | PROCESS FOR THE PREPARATION AND TREATMENT OF PROPELLANTS. | |
PL328924A1 (en) | Method of treating abuse of substances | |
NL194693B (en) | Method for the preparation of medicinal preparations for treating diabetes. | |
UST101003I4 (en) | Preventative therapy against human cancer | |
Hnat et al. | Advanced technology for the vitrification of contaminated soils | |
UA42908A (en) | Method for treating the acquired autoimmune hemolytic anemia | |
NL7800627A (en) | MODULAR LIQUID TREATMENT COMPOSITION AND METHOD FOR TREATING CONTAMINATED LIQUID. |